State NE
Clinical Trials in Nebraska
Recruiting clinical trials with at least one study location in Nebraska. Data updated daily from ClinicalTrials.gov.
Top Conditions in Nebraska
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06749457 Phase 1, Phase 2
Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase...
Condition
Staphylococcus Aureus
Enrollment
231 pts
Location
United States
Sponsor
AstraZeneca
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06799195 Phase 2
Recruiting
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Condition
Hematological Malignancies
Enrollment
126 pts
Location
United States
Sponsor
University of Nebraska
NCT05917522 Phase 2
Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Condition
Kidney Transplant
Enrollment
800 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05862272 Phase 3
Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugoli...
Condition
Uterine Fibroids
Enrollment
1,000 pts
Location
United States
Sponsor
Sumitomo Pharma Switzerland Gm
NCT07200531 N/A
Recruiting
Does Psychotherapy Change the Gut Microbiome in Women of Child-bearing Age?
Condition
Chronic Stress
Enrollment
30 pts
Location
United States
Sponsor
University of Nebraska
NCT05650541 N/A
Recruiting
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in...
Condition
Heart Failure
Enrollment
1,200 pts
Location
United States
Sponsor
Analog Device, Inc.
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05784753 N/A
Recruiting
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserv...
Condition
HFpEF - Heart Failure With Preserved Ejection Fraction
Enrollment
300 pts
Location
United States
Sponsor
University of Nebraska
NCT06107881 N/A
Recruiting
Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST...
Condition
Low Vision
Enrollment
350 pts
Location
United States
Sponsor
University of California, Los
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06938581 N/A
Recruiting
ERAS Protocols in Breast Conserving Surgery
Condition
Breast Cancer
Enrollment
260 pts
Location
United States
Sponsor
University of Nebraska
NCT07221149 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Enrollment
690 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT02432625 N/A
Recruiting
BBD Longitudinal Study of Osteogenesis Imperfecta
Condition
Osteogenesis Imperfecta
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Baylor College of Medicine
NCT06823583 N/A
Recruiting
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Gui...
Condition
Ventricular Assist Device
Enrollment
10 pts
Location
United States
Sponsor
Bryan Heart
NCT06909162 Phase 1
Recruiting
A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a...
Condition
Healthy Participants
Enrollment
51 pts
Location
United States
Sponsor
Incyte Corporation
NCT03728673 Phase 2
Recruiting
A Study Utilizing Escitalopram in Glioma Patients
Condition
Glioma of Brain
Enrollment
20 pts
Location
United States
Sponsor
University of Nebraska
NCT04485013 Phase 1
Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Condition
Cancer
Enrollment
240 pts
Location
United States
Sponsor
Tizona Therapeutics, Inc
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Condition
Colorectal Cancer
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.